Home/ISRN Oncology/Article Record
Peer-Reviewed Article June 10, 2013

Targeting of the Tumor Necrosis Factor Receptor Superfamily for Cancer Immunotherapy

Are you an author of this work?Link to your sovereign AfriScholar profile
Published in: ISRN Oncology
Publisher: Hindawi Publishing Corporation • Egypt • 2090-5661
DOI: https://doi.org/10.1155/2013/371854

Abstract

The tumor necrosis factor (TNF) ligand and cognate TNF receptor superfamilies constitute an important regulatory axis that is pivotal for immune homeostasis and correct execution of immune responses. TNF ligands and receptors are involved in diverse biological processes ranging from the selective induction of cell death in potentially dangerous and superfluous cells to providing costimulatory signals that help mount an effective immune response. This diverse and important regulatory role in immunity has sparked great interest in the development of TNFL/TNFR-targeted cancer immunotherapeutics. In this review, I will discuss the biology of the most prominent proapoptotic and co-stimulatory TNF ligands and review their current status in cancer immunotherapy.

Download Full Text PDFView at PublisherCrossref RecordCrossref XML

Verified Citation Velocity

Recorded scholarly citations in African and international peer-reviewed literature

88
Total Citations

Citations are continuously tracked and harvested across continental OJS endpoints and OpenAlex feeds.